Analysts Offer Insights on Industrial Goods Companies: Virgin Galactic Holdings (SPCE) and Electrovaya (ELVA)
There's a lot to be optimistic about in the Industrial Goods sector as 2 analysts just weighed in on Virgin Galactic Holdings (SPCE – Research Report) and Electrovaya (ELVA – Research Report) with bullish sentiments.
Confident Investing Starts Here:
Virgin Galactic Holdings (SPCE)
In a report released yesterday, Greg Konrad from Jefferies maintained a Buy rating on Virgin Galactic Holdings, with a price target of $8.00. The company's shares closed last Friday at $4.80, close to its 52-week low of $2.85.
According to TipRanks.com, Konrad is ranked #9148 out of 9558 analysts.
The word on The Street in general, suggests a Hold analyst consensus rating for Virgin Galactic Holdings with a $14.58 average price target, representing a 289.8% upside. In a report issued on May 15, TD Cowen also maintained a Buy rating on the stock with a $4.50 price target.
Electrovaya (ELVA)
In a report issued on May 15, Amit Dayal from H.C. Wainwright maintained a Buy rating on Electrovaya, with a price target of $10.00. The company's shares closed last Friday at $3.04.
According to TipRanks.com, Dayal is ranked 0 out of 5 stars with an average return of -18.7% and a 28.3% success rate. Dayal covers the Industrial Goods sector, focusing on stocks such as TOMI Environmental Solutions, Amprius Technologies Inc, and Surf Air Mobility, Inc.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Electrovaya with a $5.00 average price target, implying a 61.8% upside from current levels. In a report issued on May 7, Craig-Hallum also maintained a Buy rating on the stock.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
12 hours ago
- Business Insider
Analysts Offer Insights on Technology Companies: Nextdc Limited (OtherNXDCF) and Intuit (INTU)
There's a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Nextdc Limited (NXDCF – Research Report) and Intuit (INTU – Research Report) with bullish sentiments. Confident Investing Starts Here: Nextdc Limited (NXDCF) In a report released today, Tim Plumbe from UBS maintained a Buy rating on Nextdc Limited, with a price target of A$20.20. The company's shares closed last Tuesday at $8.91, close to its 52-week low of $8.88. According to Plumbe is a 2-star analyst with an average return of 0.2% and a 41.7% success rate. Plumbe covers the NA sector, focusing on stocks such as Corporate Travel Management Limited, Flight Centre Travel Group Limited, and WEB Travel Group. Currently, the analyst consensus on Nextdc Limited is a Strong Buy with an average price target of $12.16, a 36.5% upside from current levels. In a report issued on May 27, Citi also maintained a Buy rating on the stock with a A$18.70 price target. Intuit (INTU) Jefferies analyst Brent Thill maintained a Buy rating on Intuit yesterday and set a price target of $850.00. The company's shares closed last Tuesday at $762.10. According to Thill is a 5-star analyst with an average return of 13.9% and a 65.7% success rate. Thill covers the Technology sector, focusing on stocks such as International Business Machines, CoreWeave, Inc. Class A, and Palantir Technologies. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Intuit with a $814.71 average price target, representing a 6.9% upside. In a report issued on May 28, Scotiabank also maintained a Buy rating on the stock with a $800.00 price target.
Business Insider
20 hours ago
- Business Insider
Analysts Offer Insights on Industrial Goods Companies: Boeing (BA) and Symbotic (SYM)
Companies in the Industrial Goods sector have received a lot of coverage today as analysts weigh in on Boeing (BA – Research Report) and Symbotic (SYM – Research Report). Confident Investing Starts Here: Boeing (BA) In a report released today, Gavin Parsons from UBS maintained a Buy rating on Boeing, with a price target of $245.00. The company's shares closed last Tuesday at $215.73. According to Parsons is a 4-star analyst with an average return of 6.6% and a 66.3% success rate. Parsons covers the Industrial Goods sector, focusing on stocks such as L3Harris Technologies, StandardAero, Inc., and Northrop Grumman. Boeing has an analyst consensus of Strong Buy, with a price target consensus of $219.95, a 1.1% upside from current levels. In a report issued on June 4, Jefferies also maintained a Buy rating on the stock with a $250.00 price target. Craig-Hallum analyst Greg Palm assigned a Hold rating to Symbotic today. The company's shares closed last Tuesday at $28.23. Symbotic has an analyst consensus of Moderate Buy, with a price target consensus of $29.63.
Business Insider
2 days ago
- Business Insider
Analysts Offer Insights on Healthcare Companies: Bio-Rad Laboratories (BIO) and Ramsay Health Care (OtherRMSYF)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Bio-Rad Laboratories (BIO – Research Report) and Ramsay Health Care (RMSYF – Research Report). Confident Investing Starts Here: Bio-Rad Laboratories (BIO) RBC Capital analyst Conor McNamara maintained a Buy rating on Bio-Rad Laboratories on June 5 and set a price target of $381.00. The company's shares closed last Monday at $225.56. According to McNamara 's ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -22.5% and a 18.4% success rate. McNamara covers the Healthcare sector, focusing on stocks such as Maravai Lifesciences Holdings, SOPHiA GENETICS, and Exact Sciences. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Bio-Rad Laboratories with a $316.40 average price target. In a report released today, Steven Wheen from Jarden maintained a Hold rating on Ramsay Health Care, with a price target of A$44.05. The company's shares closed last Thursday at $24.00. According to Wheen is ranked #1103 out of 9627 analysts. The word on The Street in general, suggests a Hold analyst consensus rating for Ramsay Health Care with a $25.09 average price target.
